SJ

Sanjay Janardan Suryawanshi

Active Director Director DIN 08467319
DIN 08467319 First appointment May 2019 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjay Janardan Suryawanshi

Data last updated:

Sanjay Janardan Suryawanshi is a Director at Smj Pharmaceuticals Private Limited (since 2019). The company operates in Chemicals.

DIN 08467319
Primary Designation Director
Industry Chemicals
First Appointment 30 May 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Smj Pharmaceuticals Private Limited U24230MH2019PTC326056
Director30 May 20192019Active

Board colleagues of Sanjay Janardan Suryawanshi

NameDINCompanyDesignation
Santosh Jagannath Gadhawe08467320Smj Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Smj Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sanjay Janardan Suryawanshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Janardan Suryawanshi

Sanjay Janardan Suryawanshi currently holds 1 directorship: Smj Pharmaceuticals Private Limited (Director, since 30 May 2019).

Sanjay Janardan Suryawanshi was first appointed on 30 May 2019 as Director at Smj Pharmaceuticals Private Limited.

The current boards of Sanjay Janardan Suryawanshi's companies include Santosh Jagannath Gadhawe (Smj Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available